Application | Comment | Organism |
---|---|---|
synthesis | a KO line lacking two XylT genes and four FucT genes expressing a human IgG2 antibody shows an IgG2 expression level as high as in a control transformant. The IgG glycosylation profile shows no beta(1,2)-xylose or alpha(1,3)-fucose present on the glycosylation moiety. The dominant glycoform is the GnGn structure | Nicotiana tabacum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Nicotiana tabacum | A0A1S4AG82 | - |
- |
Nicotiana tabacum | A0A1S4DHZ6 | - |
- |
Nicotiana tabacum | D6RSA0 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
TBY-2 cell | - |
Nicotiana tabacum | - |
Synonyms | Comment | Organism |
---|---|---|
FucT | - |
Nicotiana tabacum |
FucTA | - |
Nicotiana tabacum |
FucTB | - |
Nicotiana tabacum |
FucTC | - |
Nicotiana tabacum |
LOC107797347 | locus name | Nicotiana tabacum |
LOC107830046 | locus name | Nicotiana tabacum |
NM_001324945 | - |
Nicotiana tabacum |
XM_016620229 | - |
Nicotiana tabacum |
XM_016657530 | - |
Nicotiana tabacum |
General Information | Comment | Organism |
---|---|---|
physiological function | knocking-out of two XylT genes and four FucT genes in BY-2 suspension cells using CRISPR/Cas9. Three lines show a strong reduction of beta(1,2)-xylose and alpha(1,3)-fucose, while two lines are completely devoid of them, indicating complete gene inactivation. The KO lines do not show any particular morphology and grow as the wild-type. A KO line transformed with genes encoding a human IgG2 antibody shows an IgG2 expression level as high as in a control transformant. The IgG glycosylation profile shows no beta(1,2)-xylose or alpha(1,3)-fucose present on the glycosylation moiety. The dominant glycoform is the GnGn structure | Nicotiana tabacum |